Your browser doesn't support javascript.
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
Billmeier, Arne; Khinvasara, Krutika; Lang, Franziska; Mohr, Julia; Reidenbach, Daniel; Schork, Maik; Yildiz, Ikra; Diken, Mustafa.
  • Billmeier A; BioNTech SE, Mainz, Germany.
  • Khinvasara K; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Lang F; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Mohr J; BioNTech SE, Mainz, Germany.
  • Reidenbach D; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Schork M; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Yildiz I; TRON-Translational Oncology, University Medical Center of the Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.
  • Diken M; BioNTech SE, Mainz, Germany.
Hum Vaccin Immunother ; 18(1): 2024416, 2022 12 31.
Article in English | MEDLINE | ID: covidwho-1672019
ABSTRACT
After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe's cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Prognostic study Limits: Humans Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2021.2024416

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Prognostic study Limits: Humans Language: English Journal: Hum Vaccin Immunother Year: 2022 Document Type: Article Affiliation country: 21645515.2021.2024416